KOICHI TAKAHASHI to Hematopoiesis
This is a "connection" page, showing publications KOICHI TAKAHASHI has written about Hematopoiesis.
Connection Strength
1.391
-
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. Lancet Oncol. 2017 01; 18(1):100-111.
Score: 0.434
-
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation. Cell Stem Cell. 2023 11 02; 30(11):1503-1519.e8.
Score: 0.175
-
Untangling the Relationship Between Clonal Hematopoiesis and Ovarian Cancer Therapies. J Natl Cancer Inst. 2022 04 11; 114(4):487-488.
Score: 0.157
-
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome. Cancer. 2019 07 01; 125(13):2233-2241.
Score: 0.127
-
Managing Clonal Hematopoiesis in Patients With Solid Tumors. J Clin Oncol. 2019 01 01; 37(1):7-11.
Score: 0.124
-
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell. 2018 11 01; 23(5):700-713.e6.
Score: 0.124
-
AML: Predicting the Unpredictable. Cell Stem Cell. 2018 08 02; 23(2):162-163.
Score: 0.122
-
Nrf2 regulates haematopoietic stem cell function. Nat Cell Biol. 2013 Mar; 15(3):309-16.
Score: 0.084
-
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms. Cancer Med. 2024 Mar; 13(5):e7093.
Score: 0.045